TheProfitWatch

ALLR - Allarity Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.52 -0.01 (-0.66%) --- --- --- 0.02 (1.32%) 0.0 (0.0%) 0.0 (0.0%) 0.04 (2.67%)

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: AfterHours

Earnings & Ratios

Basic EPS:
-0.15
Diluted EPS:
Basic P/E:
-10.0667
Diluted P/E:
RSI(14) 1m:
56.37
VWAP:
1.51
RVol:
0.4427

Events

Period Kind Movement Occurred At
1m Price decrease 1m 1.5 -0.03 (-1.96%) Oct 15 09:13
1m Price decrease 1m 1.5 -0.03 (-1.96%) Oct 15 08:58
1m Price increase 1m 1.52 +0.03 (+2.01%) Oct 15 08:35

Related News